What is Harrow's branded — research and development expense?

Harrow (HROW) reported branded — research and development expense of $5.62M in Q1 2026.

How has Harrow's branded — research and development expense changed year-over-year?

Harrow's branded — research and development expense increased by 182.0% year-over-year, from $1.99M to $5.62M.

What does branded — research and development expense mean?

This metric tracks the costs incurred for the discovery, clinical development, and regulatory approval of new or existing branded ophthalmic products. It reflects the company's commitment to innovation and the long-term pipeline development within the branded segment.

Harrow HROW Branded — Research And Development Expense

Other segment segments

Compounding

$210K-6.3%

Similar metrics at other companies

ANIPRare Disease and Brands — Research and Development expense

$2.81M-29.3%

BCCorporate Segment — Research and Development Expense

$1.1M+10.0%

BCRXResearch, discovery and preclinical programs — Research and Development Expense (Excluding Acquired in Process Cost)

$3.97M+30.4%

ANIPGenerics and Other — Research and Development expense

$7.79M+18.2%

ACADReportable Segment Aggregation Before Other Operating — Research And Development Expense

$76.87M-1.8%

LNTHReportable — Research And Development Expense

$39.38M+8.4%

Other financials

Income statement

See full

Revenue$44.2M-7.6%

Gross profit$27.0M-16.3%

Operating income-$22.1M-96.6%

Net income-$27.6M-55.2%

EPS (diluted)-$0.74-48.0%

Balance sheet

See full

Cash & equivalents$94.6M+41.8%

Total debt$308.6M-32.9%

Total equity$28.7M-49.1%

Total assets$419.5M+15.2%

Cash flow

See full

Operating cash flow-$9.0M-146%

CapEx$194.0K+14.1%

Free cash flow-$9.2M-147%

Valuation

See full

Market cap$1.59B+38.4%

Enterprise value$1.81B+13.8%

P/S5.9×+0.5×

Profitability

See full

Gross margin74.1%-0.4pp

Operating margin7.3%+5.2pp

Net margin-19.8%+18.0pp

FCF margin5.7%+5.0pp

Returns & leverage

See full

Return on equity-50%+17.5pp

Debt / equity10.7×+2.6×

Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's branded — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Harrow's branded — research and development expense?: Harrow (HROW) reported branded — research and development expense of $5.62M in Q1 2026.
How has Harrow's branded — research and development expense changed year-over-year?: Harrow's branded — research and development expense increased by 182.0% year-over-year, from $1.99M to $5.62M.
What does branded — research and development expense mean?: This metric tracks the costs incurred for the discovery, clinical development, and regulatory approval of new or existing branded ophthalmic products. It reflects the company's commitment to innovation and the long-term pipeline development within the branded segment.